bm-navigation: bm-t1-home-navigation-1
bm-pageheader: bm-t2-aboutus-pageheader

HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics

$60.75M funding round led by ARCH Venture Partners with 6 Dimensions Capital HiberCell will build on pioneering tumor dormancy research conducted by the Julio Aguirre-Ghiso Lab at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai NEW YORK–February 7, 2019 – /PR Newswire/–HiberCell, a biotechnology company developing therapeutics focused on preventing cancer … Continued